Current and novel therapeutic opportunities for systemic therapy in biliary cancer-Reference-Cited by-同舟云学术

Current and novel therapeutic opportunities for systemic therapy in biliary cancer

Published:2020-07-22 Issue:7 Volume:123 Page:1047-1059
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Marin José J. G.,Prete Maria Giuseppina,Lamarca Angela,Tavolari Simona,Landa-Magdalena Ana,Brandi Giovanni,Segatto Oreste,Vogel Arndt,Macias Rocío I. R.,Rodrigues Pedro M.,Casta Adelaida La,Mertens Joachim,Rodrigues Cecilia M. P.,Fernandez-Barrena Maite G.,Da Silva Ruivo Ana,Marzioni Marco,Mentrasti Giulia,Acedo Pilar,Munoz-Garrido Patricia,Cardinale Vincenzo,Banales Jesus M.,Valle Juan W.^ORCID,Bridgewater John^ORCID,Braconi Chiara^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-020-0987-3.pdf

Reference100 articles.

1. Khan, S. A., Tavolari, S. & Brandi, G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 39, 19–31 (2019).

2. Saha, S. K., Zhu, A. X., Fuchs, C. S. & Brooks, G. A. Forty‐year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 21, 594–599 (2016).

3. Kim, V. N., Han, J. & Siomi, M. C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126–139 (2009).

4. Bridgewater, J., Lopes, A., Palmer, D., Cunningham, D., Anthoney, A., Maraveyas, A. et al. Quality of life, long-term survivors and long-term outcome from the ABC-02 study. Br. J. Cancer 114, 965–971 (2016).

5. Horgan, A. M., Amir, E., Walter, T. & Knox, J. J. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J. Clin. Oncol. 30, 1934–1940 (2012).

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy with Polymeric Nanoparticles in PBRM1-Mutant Biliary Tract Cancers: Harnessing DNA Damage Repair Mechanisms;Critical Reviews in Oncology/Hematology;2024-09

2. Development and advanced applications of hepatobiliary tumor organoid models in drug response prediction;Asia-Pacific Journal of Oncology;2024-08-25

3. Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case;Frontiers in Oncology;2024-07-15

4. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01

5. Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic;BMC Cancer;2024-05-16